IMPEDIMED LIMITED — Director's Dealing 2025

Nov 5, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: ImpediMed Limited ABN: 089 705 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Ms Christine Emmanuel-Donnelly
Date of last notice	01 August 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Mr John Charles Donnelly and Ms Christine Anna Marie Emmanuel-Donnelly as trustee for Donnelly Superannuation Fund Ms Emmanuel-Donnelly is a trustee of the superannuation fund and a beneficiary of the fund. IDEAHL Pty Ltd as trustee for Donnelly Family Trust Ms Emmanuel-Donnelly is a director of IDEAHL Pty Ltd and a beneficiary of the trust.
Date of change	03 November 2025

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change		Direct 318,116 Ordinary shares Donnelly Superannuation Fund 1,736,255 Ordinary shares IDEAHL Pty Ltd 1,369,026 Ordinary shares
Class		Ordinary shares
Number acquired		IDEAHL Pty Ltd 143,182 Ordinary shares
Number disposed		Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		$0.0363 per share
No. of securities held after change		Direct 318,116 Ordinary shares Donnelly Superannuation Fund 1,736,255 Ordinary shares IDEAHL Pty Ltd 1,512,208 Ordinary shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issue of shares in lieu of 15% of director fees for quarter ended 30 September 2025.

Part 2 – Change of director’s interests in contracts

Not applicable.

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired

• See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

Date of Notice: 06 November 2025

• See chapter 19 for defined terms.

Appendix 3Y Page 3